Before 2016 , the enterprise signed a contract that will multiply in two fold its drugs operation in Latin America .
In May 2014 , the company entered into a binding agreement to acquire Chilean generic pharmaceutical company CFR in a deal worth $ 2.9 billion which the company said would more than double its branded generic drug portfolio .
Abbott Laboratories